EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Is It Feasible of Prophylactic Alpha-5 GABA(A) Receptor Blockade for Preventing POCD?

Fuzhou Wang

Science Insights · 2013

DOI: 10.15354/si.13.rp011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Insights, 2013. Verfasst von Fuzhou Wang. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GAMMA-AMINOBUTYRIC ACID (GABA) is the chief inhibitory neurotransmitter in the mammalian central nervous system (CNS). It plays a role in regulating neuronal excitability throughout the nervous system. Also GABA activation is considered as the basis of general anesthesia including intravenous and inhalational anesthetics. Meanwhile, cumulating evidence indicated that GABA is the underlying mechanism of post-operative cognitive dysfunction (POCD). Based on these findings, researchers are beginning to focus on GABA as the target to treat POCD, but they ignored the role of GABA in the performance of general anesthesia, especially when the blockade of GABA was given prior to surgery. It is undoubtedly risking our patients in intra-operative awareness. Our exploratory data also verified our hypothesis in which the GABA inhibition would reduce the efficacy of inhalational anesthetics.

Zitieren

APA

Wang, F. (2013). Is It Feasible of Prophylactic Alpha-5 GABA(A) Receptor Blockade for Preventing POCD?. Science Insights. https://doi.org/10.15354/si.13.rp011

Vancouver

Wang F. Is It Feasible of Prophylactic Alpha-5 GABA(A) Receptor Blockade for Preventing POCD?. Science Insights. 2013. doi:10.15354/si.13.rp011

BibTeX
@article{Wang2013,
  author = {Wang, Fuzhou},
  title = {Is It Feasible of Prophylactic Alpha-5 GABA(A) Receptor Blockade for Preventing POCD?},
  journal = {Science Insights},
  year = {2013},
  doi = {10.15354/si.13.rp011}
}
Kostenlos starten →